IVD PRODUCT ENDO PREDICT庐 漏 2023 The second generation of multi-gene for prognostic prediction of breast cancer Highlights Fifteen years of prognostic validation data provided more accurate recurrence risk assessment Recommended by domestic diagnosis and treatment guidelines Recommended by international authoritative medical guidelines MYRAID GENETICS exclusive strategic partnership Exclusive introduction by Shuwen Biotech. PREFERRED POPULATION … Continue reading IVD PRODUCT | Endo Predict庐锔廃/span>